Evidence map›Paper›PMID 30464515›Full record

ArticleOncoTargets and therapy2018

Cytotoxic effect of

Maryam Hamzeloo-Moghadam, Mahmoud Aghaei, Mohammad Hossein Abdolmohammadi, Amir Khalaj, Faranak Fallahian

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Phytochemical Analysis and Anticancer Properties ofMolecules (Basel, Switzerland) · 2023
    Article
  5. Article
  6. SelectiveToxicology reports · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Maryam Hamzeloo-MoghadamTraditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mahmoud AghaeiDepartment of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad Hossein AbdolmohammadiCellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran, ffalahian@muq.ac.ir.
Amir KhalajTraditional Medicine and Materia Medica Research Center and Department of Traditional Pharmacy, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Faranak FallahianCellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran, ffalahian@muq.ac.ir.
Qom University of Medical Science and Health Services · IRIsfahan University of Medical Sciences · IRMinistry of Health and Medical Education · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMATERIALS AND

methodsIn the current study, cell viability, apoptosis induction, ROS production, mitochondrial apoptotic pathway, and ER stress mediators have been evaluated in breast cancer cells, MCF7, and MDA-MB-468 treated with

resultsSignificant cytotoxic effects were observed in MCF-7 and MDA-MB-468 cells after exposure to

conclusionThese data suggest that

Indexed as

apoptosisbreast cancerDrimia maritimaER stressmitochondriaROS

Identifiers

PMID30464515
PMCPMC6217182
OpenAlexW2898701285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.